Works by Byoung Chul Cho
Results: 125
Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea.
- Published in:
- Lung Cancer: Targets & Therapy, 2024, v. 15, p. 149, doi. 10.2147/LCTT.S485320
- By:
- Publication type:
- Article
RNF25 promotes gefitinib resistance in EGFR-mutant NSCLC cells by inducing NF-κB-mediated ERK reactivation.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 6, p. 1, doi. 10.1038/s41419-018-0651-5
- By:
- Publication type:
- Article
Molecular characterization of lung adenocarcinoma from Korean patients using next generation sequencing.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224379
- By:
- Publication type:
- Article
Neoadjuvant therapy for thymic neoplasms reduces tumor volume per 3D-reconstructed images but does not improve the complete resection rate.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0214291
- By:
- Publication type:
- Article
High CD3 and ICOS and low TIM-3 expression predict favourable survival in resected oesophageal squamous cell carcinoma.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56828-7
- By:
- Publication type:
- Article
Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56356-4
- By:
- Publication type:
- Article
NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47755-8
- By:
- Publication type:
- Article
Nivolumab in NSCLC: latest evidence and clinical potential.
- Published in:
- Therapeutic Advances in Medical Oncology, 2015, v. 7, n. 2, p. 85, doi. 10.1177/1758834014567470
- By:
- Publication type:
- Article
Correction: Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.
- Published in:
- British Journal of Cancer, 2020, v. 122, n. 11, p. 1649, doi. 10.1038/s41416-020-0796-8
- By:
- Publication type:
- Article
Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response.
- Published in:
- 2020
- By:
- Publication type:
- journal article
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor–resistant lung cancer therapy.
- Published in:
- Experimental & Molecular Medicine EMM, 2022, v. 54, n. 8, p. 1236, doi. 10.1038/s12276-022-00836-7
- By:
- Publication type:
- Article
DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway.
- Published in:
- Experimental & Molecular Medicine EMM, 2021, v. 53, n. 4, p. 643, doi. 10.1038/s12276-021-00601-2
- By:
- Publication type:
- Article
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer.
- Published in:
- Experimental & Molecular Medicine EMM, 2020, p. 1550, doi. 10.1038/s12276-020-00493-8
- By:
- Publication type:
- Article
Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. 601, doi. 10.1016/j.cllc.2021.06.006
- By:
- Publication type:
- Article
Patient-Reported Outcomes with Durvalumab With or Without Tremelimumab Versus Standard Chemotherapy as First-Line Treatment of Metastatic Non–Small-Cell Lung Cancer (MYSTIC).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 301, doi. 10.1016/j.cllc.2021.02.010
- By:
- Publication type:
- Article
Design and Rationale for a Phase III, Randomized, Placebo-controlled Trial of Durvalumab With or Without Tremelimumab After Concurrent Chemoradiotherapy for Patients With Limited-stage Small-cell Lung Cancer: The ADRIATIC Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Real‐world treatment patterns and clinical outcomes in patients with stage III NSCLC in Korea: The KINDLE study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7174
- By:
- Publication type:
- Article
A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 7012, doi. 10.1002/cam4.4231
- By:
- Publication type:
- Article
Optimal dose and volume for postoperative radiotherapy in brain oligometastases from lung cancer: a retrospective study.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 2, p. 153, doi. 10.3857/roj.2017.00094
- By:
- Publication type:
- Article
Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance.
- Published in:
- Genome Medicine, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13073-015-0219-2
- By:
- Publication type:
- Article
Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing.
- Published in:
- PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0294857
- By:
- Publication type:
- Article
Frequent Central Nervous System Failure After Clinical Benefit With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Korean Patients With Nonsmall-Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 5, p. 1336, doi. 10.1002/cncr.24877
- By:
- Publication type:
- Article
Establishment and characterization of patient-derived xenografts as paraclinical models for head and neck cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients.
- Published in:
- Oncology, 2011, v. 79, n. 3/4, p. 293, doi. 10.1159/000323333
- By:
- Publication type:
- Article
Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1117348
- By:
- Publication type:
- Article
Exploring aryl hydrocarbon receptor expression and distribution in the tumor microenvironment, with a focus on immune cells, in various solid cancer types.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1330228
- By:
- Publication type:
- Article
Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0137678
- By:
- Publication type:
- Article
Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 20, p. 4521, doi. 10.1002/cncr.33123
- By:
- Publication type:
- Article
Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2612, doi. 10.1002/cncr.29401
- By:
- Publication type:
- Article
Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 3, p. 729, doi. 10.1002/cncr.26311
- By:
- Publication type:
- Article
A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-795
- By:
- Publication type:
- Article
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
- Published in:
- Thyroid, 2024, v. 34, n. 1, p. 26, doi. 10.1089/thy.2023.0363
- By:
- Publication type:
- Article
Amivantamab compared with real-world therapies in patients with advanced non-small cell lung cancer EGFR Exon 20 insertion mutations after platinum-based chemotherapy.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 12, p. 1689, doi. 10.1080/0284186X.2023.2254479
- By:
- Publication type:
- Article
Novel allosteric glutaminase inhibitors with macrocyclic structure activity relationship analysis (part 2).
- Published in:
- Bulletin of the Korean Chemical Society, 2024, v. 45, n. 7, p. 639, doi. 10.1002/bkcs.12883
- By:
- Publication type:
- Article
Identification of TRE‐130 as Reversible Inhibitor of Pan‐EGFR Mutants while Sparing EGFR Wild‐Type Activity.
- Published in:
- Bulletin of the Korean Chemical Society, 2019, v. 40, n. 12, p. 1222, doi. 10.1002/bkcs.11886
- By:
- Publication type:
- Article
Allosteric Inhibitor TREA‐0236 Containing Non‐hydrolysable Quinazoline‐4‐one for EGFR T790M/C797S Mutants Inhibition.
- Published in:
- Bulletin of the Korean Chemical Society, 2018, v. 39, n. 7, p. 895, doi. 10.1002/bkcs.11491
- By:
- Publication type:
- Article
Structure-Activity Relationship Study of 2,4-Dianilinopyrimidine Containing Methanesulfonamide (TRE-069) as Potent and Selective Epidermal Growth Factor Receptor T790M/C797S Mutant Inhibitor for Anticancer Treatment.
- Published in:
- Bulletin of the Korean Chemical Society, 2017, v. 38, n. 11, p. 1353, doi. 10.1002/bkcs.11287
- By:
- Publication type:
- Article
Comprehensive analysis of the characteristics and treatment outcomes of patients with non-small cell lung cancer treated with anti-PD-1 therapy in real-world practice.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1613, doi. 10.1007/s00432-019-02899-y
- By:
- Publication type:
- Article
Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 12, p. 1937, doi. 10.1007/s00432-010-0853-4
- By:
- Publication type:
- Article
Architectural patterns of p16 immunohistochemical expression associated with cancer immunity and prognosis of head and neck squamous cell carcinoma.
- Published in:
- APMIS, 2017, v. 125, n. 11, p. 974, doi. 10.1111/apm.12744
- By:
- Publication type:
- Article
PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.
- Published in:
- Scientific Reports, 2016, p. 36956, doi. 10.1038/srep36956
- By:
- Publication type:
- Article
Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 4, p. 547, doi. 10.1080/02841860601009463
- By:
- Publication type:
- Article
Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study.
- Published in:
- Head & Neck, 2024, v. 46, n. 5, p. 1152, doi. 10.1002/hed.27726
- By:
- Publication type:
- Article
Characterization of head and neck squamous cell carcinoma arising in young patients: Particular focus on molecular alteration and tumor immunity.
- Published in:
- Head & Neck, 2019, v. 41, n. 1, p. 198, doi. 10.1002/hed.25507
- By:
- Publication type:
- Article